Recalls / Active ingredient / Meclizine Hydrochloride
Meclizine Hydrochloride
6 FDA drug recalls involving the active ingredient “Meclizine Hydrochloride” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-03-16 | Class II | Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individua | Amerisource Health Services LLC |
| 2022-04-13 | Class II | Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-03-08 | Class I | Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Ma | Jubilant Cadista Pharmaceuticals, Inc. |
| 2019-10-01 | Class III | WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-183 | Sato Pharmaceutical Inc. |
| 2019-10-01 | Class III | Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. | Sato Pharmaceutical Inc. |
| 2017-10-30 | Class III | Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadist | Jubilant Cadista Pharmaceuticals, Inc. |